Author | Mohammad Jahanzeb, MD


Rationale for Trials Studying Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer

October 01, 1997

ByMohammad Jahanzeb, MD|Cynthia Frankel, RN|Mohammed Elkersh, MD|Alan Koletsky, MD|Peter Radice, MD|Charles L. Vogel, MD, FACP

Breast cancer is second only to lung cancer as a leading cause of cancer mortality in women. In women with metastatic, hence, essentially incurable disease, we strive to find effective chemotherapeutic regimens that offer a